PEG-Intron
PEG-Intron
PEG-Intron (pronounced: PEG-In-tron), also known as Peginterferon alfa-2b, is a medication used in the treatment of certain viral infections, most notably Hepatitis C. It is a form of interferon, a type of protein that the body naturally produces to combat viruses, that has been modified with polyethylene glycol (PEG) to improve its effectiveness and duration of action.
Etymology
The name "PEG-Intron" is derived from the terms "PEG", short for polyethylene glycol, and "Intron", a brand name for interferon products produced by the pharmaceutical company Merck & Co.. The "alfa-2b" part of the name "Peginterferon alfa-2b" refers to the specific subtype of interferon that the medication is based on.
Usage
PEG-Intron is used primarily in the treatment of chronic Hepatitis C, a viral infection that affects the liver. It is often used in combination with other antiviral medications, such as ribavirin, to increase the chances of curing the infection. The medication works by stimulating the body's immune system to fight off the virus.
Side Effects
Like all medications, PEG-Intron can cause side effects. The most common ones include flu-like symptoms, such as fever, chills, and muscle aches, as well as fatigue, loss of appetite, and mood changes. More serious side effects can include depression, changes in vision, and severe stomach or back pain.
Related Terms
External links
- Medical encyclopedia article on PEG-Intron
- Wikipedia's article - PEG-Intron
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski